Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>A study of clinical trials involving cancer drugs over the past decade shows that the problem of studies enrolling too few racial and ethnic minorities has not improved, although the issue has been raised publicly for years.</p>

Study: Minorities Remain Underrepresented in Cancer Trials

IRBs, PIs can work toward diversity